Drug intelligence / Profile preview

Funing Capsules

Development stage: Unknown
Lead developer: Hebei Wanbang Fu Lin Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Funing Capsules (妇宁胶囊) is a traditional Chinese medicine (TCM) formulation developed and manufactured by Hebei Wanbang Fu Lin Pharmaceutical. It is an oral capsule primarily indicated for gynecological inflammatory conditions, such as chronic pelvic inflammatory disease (PID), adnexitis, and endometritis. According to TCM theory, the formulation is designed to clear heat, detoxify, resolve blood stasis, and alleviate pain. It is commonly used to treat symptoms including lower abdominal distension and pain, as well as increased or abnormal vaginal discharge (leucorrhea) associated with damp-heat and blood stasis. The product is currently approved and marketed in China.

Brand names: Funing Capsules妇宁胶囊
Other names: 妇宁胶囊

Beyond the preview

Go deeper on Funing Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Funing Capsules.

Explore the full profile